Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/111398
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSanchez-Mut, Jose Vicente-
dc.contributor.authorHeyn, Holger-
dc.contributor.authorVidal, Enrique-
dc.contributor.authorMoran, Sebastian-
dc.contributor.authorSayols, Sergi-
dc.contributor.authorDelgado-Morales, Raúl-
dc.contributor.authorSchultz, M. D.-
dc.contributor.authorAnsoleaga, Belén-
dc.contributor.authorGarcia Esparcia, Paula-
dc.contributor.authorPons-Espinal, Meritxell-
dc.contributor.authorLagran, M. M. de-
dc.contributor.authorDopazo, Joaquín-
dc.contributor.authorRabano, A.-
dc.contributor.authorAvila, Jesús-
dc.contributor.authorDierssen, Mara-
dc.contributor.authorLott, I.-
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)-
dc.contributor.authorEcker, J. R.-
dc.contributor.authorEsteller, Manel-
dc.date.accessioned2017-05-22T11:43:05Z-
dc.date.available2017-05-22T11:43:05Z-
dc.date.issued2016-01-19-
dc.identifier.issn2158-3188-
dc.identifier.urihttp://hdl.handle.net/2445/111398-
dc.description.abstractDifferent neurodegenerative disorders often show similar lesions, such as the presence of amyloid plaques, TAU-neurotangles and synuclein inclusions. The genetically inherited forms are rare, so we wondered whether shared epigenetic aberrations, such as those affecting DNA methylation, might also exist. The studied samples were gray matter samples from the prefrontal cortex of control and neurodegenerative disease-associated cases. We performed the DNA methylation analyses of Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease and Alzheimer-like neurodegenerative profile associated with Down's syndrome samples. The DNA methylation landscapes obtained show that neurodegenerative diseases share similar aberrant CpG methylation shifts targeting a defined gene set. Our findings suggest that neurodegenerative disorders might have similar pathogenetic mechanisms that subsequently evolve into different clinical entities. The identified aberrant DNA methylation changes can be used as biomarkers of the disorders and as potential new targets for the development of new therapies.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/tp.2015.214-
dc.relation.ispartofTranslational Psychiatry, 2016, vol. 6, p. e718-
dc.relation.urihttps://doi.org/10.1038/tp.2015.214-
dc.rightscc-by-nc-nd (c) Sanchez-Mut, Jose Vicente et al., 2016-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.subject.classificationEpigènesi-
dc.subject.classificationADN-
dc.subject.classificationMetilació-
dc.subject.classificationMalalties neurodegeneratives-
dc.subject.classificationSistema nerviós-
dc.subject.otherEpigenesis-
dc.subject.otherDNA-
dc.subject.otherMethylation-
dc.subject.otherNeurodegenerative diseases-
dc.subject.otherNervous system-
dc.titleHuman DNA methylomes of neurodegenerative diseases show common epigenomic patterns-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec662706-
dc.date.updated2017-05-22T11:43:05Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
662706.pdf3.29 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons